Agneta Nordberg, MD, PhD from the Karolinska University Hospital Huddinge, Solna, Sweden provides her insight on the session she chaired, ‘Relationship Between Tau and Amyloid Imaging Biomarkers’, at the Alzheimer’s Association International Conference (AAIC) 2017, London, UK. A lot of new information and data were presented during the session, highlighting the progress made in this field. Due to improved imaging of amyloid and tau in patients with Alzheimer’s disease (AD, it is possible to obtain a better understand of how these proteins interact and what their role is in the pathology and progression of AD.